1. Scrip
  2. >>Business
  3. >>Deals

Nastor offer for Celsis unconditional

 
• By Sita Shah

Nastor Investments' offer for Celsis International has become unconditional. KBC Peel Hunt put in a recommended all-cash offer worth $54.5 million, or 232.5 pence per share, on behalf of the US private equity firm last month (scripnews.com, August 3rd, 2009).

Nastor Investments' offer for Celsis International has become unconditional. KBC Peel Hunt put in a recommended all-cash offer worth $54.5 million, or 232.5 pence per share, on behalf of the US private equity firm last month (scripnews.com, August 3rd, 2009).

Celsis and Nastor have reached an agreement on the recommended offer. As of 1pm yesterday, Nastor either owned or had received valid acceptances of an aggregate of 15 million Celsis...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business

Challenging Environment For Biopharma Is A Tailwind For Royalty Pharma

 
• By Jessica Merrill

The royalty revenue stream acquirer has around 40 products in its portfolio and expects to generate roughly $3bn this year. Head of R&D and investments Marshall Urist talked about the investment strategy at the RBC Healthcare Conference.

Finance Watch: SV Closes Second Dementia Discovery Fund, Exceeding $250m Goal

 
• By Mandy Jackson

Private Company Edition: SV Health Investors revealed the final closing of its second Dementia Discovery Fund. Also, Eikon cut nearly 15% of its staff, Pathos AI raised $365m in series D venture capital and CellCentric completed a $120m series C round, among other financings.

Sanofi Makes Alzheimer’s Bet With Vigil Buy

 
• By Kevin Grogan

The French drugmaker is expanding its neurology activities with the $470m deal.